Company: ANTX
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0000950170-25-052852
Chunk: 40

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 40
---
 the release of material nonpublic information for the purpose of affecting the value of executive compensation . During fiscal year 2024 , we did not grant stock options, stock appreciation rights, or similar option-like instruments to our named executive officers during the four business days prior to or the one business day following the filing of our periodic reports or the filing or furnishing of a Form 8-K that discloses material nonpublic information.

Hedging and Pledging Policies

Pursuant to our Insider Trading Policy, all employees (including executive officers) and directors are prohibited from trading in puts or calls or other derivative or hedging transactions in our securities. All employees (including executive officers) and directors are also prohibited from including our securities in a margin account or pledging our securities as collateral for a loan. Further, it is against Company policy for any employee (including any executive officers) or director to engage in short sales of our common stock. Any violation of the policies may result in disciplinary action, including dismissal for cause.

<div align='center'>21</div>

COMPENSATION OF NON -EMPLOYEE DIRECTORS The following table sets forth information concerning compensation earned by the non-employee members of our Board in fiscal year 2024. Mr. Easom, our President, Chief Executive Officer and Board chair, is also a director but does not receive any additional compensation for his services as a director. Information concerning the compensation earned by Mr. Easom is set forth in the section titled “Executive Compensation.”

| Name                     | ﻿ | Fees Earned or Paid in Cash ($)(1) |        |     | ﻿ | Option Awards 
 ($)(2)        |         |     | Stock Awards 
 ($)(1)       |     |     | Total ($) |         |
| Kabeer Aziz              | ﻿ |                                    | 43,553 |     |   |               | 104,514 |     |              | 769 |     |           | 148,836 |
| Margaret FitzPatrick     |   |                                    | 54,568 |     |   |               | 104,514 |     |              |   — |     |           | 159,082 |
| Gilbert Lynn Marks, M.D. | ﻿ |                                    | 44,582 |     |   |               | 104,514 |     |              | 769 |     |           | 149,865 |
| Patricia Martin          | ﻿ |                                    | 54,384 |     |   |               |